Third day of isolation for Sierra Leoneans. With the exception of health workers and special permits, the inhabitants of Sierra Leone have been confined to their homes since Friday and until Sunday, 6 p.m., to avoid the active resumption of theEbola virus outbreak which is not completely finished in the country.
Ebola: more than 3,700 dead in Sierra Leone
The Ebola epidemic appeared in December 2013 in southern Guinea, then spread in Liberia and Sierra Leone.
These three countries account for more than 99% of the more than 10,300 deaths identified in some 25,000 cases, according to the latest report from theWorld Health Organization (WHO) arrested on March 22, 2015. These countries hope to reach zero cases by mid-April.
In Sierra Leone, more than 3,700 deaths have been recorded out of more than 11,800 Ebola cases according to the same WHO report.
Second confinement in 6 months for Sierra Leone
A first sanitary confinement had already been imposed on the entire population of this country from September 17 to 19, 2014.
It was in the face of an upsurge in cases in certain areas that risked compromising the general ebb noted since December 2014 that this new isolation was decided, according to the authorities, who also want to reduce the risks at the approach of the reopening of schools, April 14, after eight months of closure.
This containment campaign places more emphasis on four districts: the West region, Port Kolo, Bombali and Kambia (north), near Forécariah, where the current outbreaks are located.
A determined effort to rid the country of Ebola
Some easing of lockdown restrictions were seen over the weekend to allow Muslims to perform the weekly big prayer and Christians to go to mass on Palm Sunday.
The people of Sierra Leone have expressed their full support for the containment, seeing it as “a determined effort to rid the country of Ebola,” government spokesman Abdulai Bayratay said, citing reports received from all regions.
Read also :
– Ebola fighters, personalities of the year for the Times
– Ebola: the first trials of two successful vaccines
